Radar Healthcare acquires Cemplicity in patient outcomes push
Radar Healthcare, the Leeds-based health and care quality management software company, has acquired Cemplicity, a platform specialising in patient-reported experience measures (PREMs), patient-reported outcome measures (PROMs), and real-time patient feedback. Financial terms were not disclosed.
The deal marks Radar Healthcare's second acquisition in a short period, following its earlier purchase of EIDO Healthcare, which added digital consent and patient information capabilities to the group. The Cemplicity transaction extends that build-out further, bringing surgical site inspection surveillance, service recovery feedback, shared decision-making insights and post-care outcome measurement under the same roof as Radar Healthcare's existing quality, risk, compliance, incident management and audit tools.
The deal
Edward Bellamy at Radar Healthcare said the two businesses share a common purpose. "Cemplicity brings deep expertise in patient experience, patient-reported outcomes and real-time patient insight, which strongly complements Radar Healthcare's quality, risk, compliance and improvement platform. Together, we can help customers connect what patients are experiencing with the workflows needed to act on that insight and drive meaningful improvement."
Blaik Wilson at Cemplicity said the acquisition would allow the company to extend its reach. "Joining Radar Healthcare gives us an exciting opportunity to build on that work, extend our impact and support more organisations in using patient-reported insight to improve care."
Both companies confirmed that existing customers will continue to receive their current service and product access without disruption. Longer-term integration of the two platforms is described as exploratory, with no specific timeline given.
Radar Healthcare is backed by private equity firm Marlin Equity Partners, which the company said provides strategic support as it continues to invest in its platform and customer success capabilities. The backing suggests further consolidation within the healthcare quality management space is plausible.
Market context
The acquisition reflects a broader trend in digital health towards connecting governance and compliance software with patient-generated data. Historically, quality and risk management systems in NHS and private healthcare settings have operated in isolation from patient feedback tools, creating a gap between what clinical governance teams record and what patients actually report about their care. Vendors are increasingly competing to close that gap by offering integrated platforms that route patient-reported signals directly into improvement workflows.
A number of UK and international vendors, including established electronic patient record providers and niche quality management specialists, are active in this space. Radar Healthcare's strategy of bolt-on acquisitions to broaden its feature set is a common playbook for PE-backed health IT businesses seeking to move from point solution to platform. The EIDO and Cemplicity deals together suggest the company is positioning itself as an end-to-end patient engagement and governance platform, a category with growing traction among NHS trusts and independent healthcare providers looking to meet evolving Care Quality Commission expectations around patient involvement and measurable outcomes.
Investors and potential customers will be watching to see how quickly the two product sets can be technically integrated, and whether a unified data model linking PREMs, PROMs and incident workflows can be demonstrated in a live customer environment.